You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Inhibition of methanogenesis

    SBC: BIONEBRASKA, INC.            Topic: N/A

    DESCRIPTION:(provided by applicant) The goal of this project is to develop a novel inhibitor of methane formation in ruminant animals. Currently, monensin, a relatively nonspecific antibiotic, is widely used in the livestock industry. Monensin increases agricultural productivity by decreasing methane and increasing propionate production; however, it also inhibits ...

    STTR Phase I 2001 Department of Health and Human ServicesNational Institutes of Health
  2. OTOREFLECTANCE ASSESSMENT OF MIDDLE-EAR FUNCTIONING

    SBC: Sonicom, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): Otoreflectance (OR) is a new class of hearing test instruments utilizing acoustic signals presented and recorded in the ear canal. OR instruments address limitations in existing screening and diagnostic instruments in such areas as: (1) detecting otitis media, (2) predicting conductive hearing loss, (3) augmenting the newborn hearing screening protocol to test ...

    STTR Phase I 2003 Department of Health and Human ServicesNational Institutes of Health
  3. A Peptide-Based Vaccine to Nicotine

    SBC: Prommune, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The primary objective of this Phase I STTR project is to develop an effective, peptide-based nicotine vaccine for use in humans capable of inducing a robust, nicotine-specific antibody (Ab) response with little or no inflammatory side effects. This will be accomplished by a vaccine design in which a conformationally biased, response-selective agonist Of C5a ( ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  4. The Molecular Culture

    SBC: TRANSGENOMIC, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): In the clinical setting, molecular microbiologic detection methods have classically focused on a single microorganism or a small group of microorganisms. Broad range molecular detection of bacteria in clinical specimens is an approach that parallels a conventional culture-based approach, may be more rapid, and offers the possibility of identifying so-called "n ...

    STTR Phase I 2004 Department of Health and Human ServicesNational Institutes of Health
  5. POWER: Political Will Expert Reasoning Tool

    SBC: 21ST CENTURY SYSTEMS, INC.            Topic: OSD07T002

    There are many challenges in addressing the problem of Political Will. The first is developing a clear, complete, consensual definition of Political Will driven by both theory and field practice. But a larger challenge is deconstructing and unpacking the Political Science and Social Science concept of Political Will into its complex constituent elements in order to arrive at their computational, r ...

    STTR Phase I 2007 Department of DefenseArmy
  6. Terahertz Ellipsometry for Reflection-Mode Material Characterization

    SBC: J. A. Woollam Co., Inc.            Topic: A08T013

    As technologies utilizing THz radiation (light) are developed, the optical properties for many materials need to be determined accurately as a function of frequency. In a security screening system, measured optical properties might be used to distinguish, independent of shape, between threat and background materials. Improved optical elements for increasingly advanced THz systems will require op ...

    STTR Phase I 2008 Department of DefenseArmy
  7. Response-Selective C5a Agonist for the Treatment of Asthma

    SBC: Prommune, Inc.            Topic: NIAID

    DESCRIPTION (provided by applicant): An unmet need in the treatment of allergic asthma is an effective therapeutic strategy that focuses on an underlying cause of the disease rather than merely treating or managing its symptoms. At least one well- accepted underlying contributor to the pathophysiologic expression of asthma is an over-expressed and dysregulated T helper type 2 (Th2)-mediated immun ...

    STTR Phase I 2011 Department of Health and Human ServicesNational Institutes of Health
  8. RADIOGRAPHIC CONTRAST TO DIFFERENTIATE CAVITATED FROM NON-CAVITATED DENTAL CARIES

    SBC: FIREFLY HEALTH INNOVATIONS NE, INC.            Topic: NIDCR

    DESCRIPTION (provided by applicant): This project relates directly to the PHS 2011-2, Omnibus Solicitation for SBIR/STTR Grant Application page NIDCR 110: Development of instrumentation for early caries detection and comparison studies on specificity andselectivity with respect to current clinical practice. The proposed test is intended to enable dentists to differentiate between cavitated and ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  9. Development of Ultrafine Particles for Intranasal Delivery of Antipsychotics

    SBC: LNKCHEMSOLUTIONS            Topic: NIMH

    DESCRIPTION: The goal of the proposed project is to develop a biocompatible ultrafine particle-based vector system for the intranasal delivery of clozapine for the pharmacological therapy of treatment- resistant schizophrenic disorders and their associatedsuicidal behavior. The rationale behind the use of intranasal clozapine is grounded on the observation of clozapine's extensive first- pass ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
  10. Early Detection of Pancreatic Cancer Using Ice COLD-PCR

    SBC: TRANSGENOMIC, INC.            Topic: NCATS

    DESCRIPTION (provided by applicant): Ninety percent of all pancreatic cancers are pancreatic ductal adenocarcinoma (PDAC). PDAC diagnosis is difficult, usually occurring in the late stages of disease. Patients with these advanced tumors typically respondpoorly to therapy. Post diagnosis, median survival is 6 months and the five-year survival rate is lt 4%. Five-year survival is lt 1% for those wi ...

    STTR Phase I 2012 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government